Xpert® MTB/XDR
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Brand name
- Xpert®
- Commercial name
- 21-610.- Reagents/Kits for IVD Assays, Molecular Assay, Infection, Bacteria, Mycobacterium tuberculosis, DNA
- Sterilization method
- METHODOLOGY: MOLECULAR BIOLOGY
- Analysis ID
- feb81cc0013eea3da959e08b75aa1238
- Registration date
- January 05, 2022
- Expiration date
- January 05, 2027
- Creation date
- May 01, 2022
- Name
- CEPHEID
- City
- SUNNYVALE, CA
- Country
- UNITED STATES
- Address
- 904 CARIBBEAN DRIVE SUNNYVALE CA, 94089 USA
- Name
- CEPHEID AB
- Country
- SWEDEN
- Address
- TODOS LOS SANTOS # 201 AND AV. JORGE PEREZ CONCHA
- Phone
- 2610680
FOR DNA DETECTION OF THE MYCOBACTERIUM TUBERCULOSIS (MTB) WITH EXTENSIVE DRUG RESISTANCE (XDR) IN RAW SPUTUM SAMPLES, IN CONCENTRATED SEDIMENTS PREPARED FROM SPUTUM OR IN CULTURE WITH BD™ MYCOBACTERIAL GROWTH INDICATOR TUBE (MGIT).™
Access comprehensive regulatory information for Xpert® MTB/XDR in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID feb81cc0013eea3da959e08b75aa1238 and manufactured by CEPHEID. The device was registered on January 05, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.